Susanne Schlisios forskargrupp

Publikationer

Utvalda publikationer

Article: NATURE METABOLISM. 2022;4(6):739-758
Impaired oxygen-sensitive regulation of mitochondrial biogenesis within the von Hippel-Lindau syndrome
Li S; Li W; Yuan J; Bullova P; Wu J; Zhang X; Liu Y; Plescher M; Rodriguez J; Bedoya-Reina OC; Jannig PR; Valente-Silva P; Yu M; Henriksson MA; Zubarev RA; Smed-Sorensen A; Suzuki CK; Ruas JL; Holmberg J; Larsson C; Christofer Juhlin C; von Kriegsheim A; Cao Y; Schlisio S
Article: NATURE COMMUNICATIONS. 2021;12(1):5309
Single-nuclei transcriptomes from human adrenal gland reveal distinct cellular identities of low and high-risk neuroblastoma tumors
Bedoya-Reina OC; Li W; Arceo M; Plescher M; Bullova P; Pui H; Kaucka M; Kharchenko P; Martinsson T; Holmberg J; Adameyko I; Deng Q; Larsson C; Juhlin CC; Kogner P; Schlisio S
Article: NUCLEIC ACIDS RESEARCH. 2021;49(5):2509-2521
Aberrant splicing in neuroblastoma generates RNA-fusion transcripts and provides vulnerability to spliceosome inhibitors
Shi Y; Yuan J; Rraklli V; Maxymovitz E; Cipullo M; Liu M; Li S; Westerlund I; Bedoya-Reina OC; Bullova P; Rorbach J; Juhlin CC; Stenman A; Larsson C; Kogner P; O'Sullivan MJ; Schlisio S; Holmberg J
Letter: CANCER CELL. 2021;39(2):134-135
Chromaffin Cells with Sympathoblast Signature: Too Similar to Keep Apart?
Bedoya-Reina OC; Schlisio S
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2019;116(34):16997-17006
EglN3 hydroxylase stabilizes BIM-EL linking VHL type 2C mutations to pheochromocytoma pathogenesis and chemotherapy resistance
Li S; Rodriguez J; Li W; Bullova P; Fell SM; Surova O; Westerlund I; Topcic D; Bergsland M; Stenman A; Muhr J; Nister M; Holmberg J; Juhlin CC; Larsson C; von Kriegsheim A; Kaelin WGJ; Schlisio S
Article: CELL REPORTS. 2018;24(5):1316-1329
PHD3 Regulates p53 Protein Stability by Hydroxylating Proline 359
Rodriguez J; Herrero A; Li S; Rauch N; Quintanilla A; Wynne K; Krstic A; Acosta JC; Taylor C; Schlisio S; von Kriegsheim A
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2017;114(30):E6137-E6146
Combined epigenetic and differentiation-based treatment inhibits neuroblastoma tumor growth and links HIF2α to tumor suppression
Westerlund I; Shi Y; Toskas K; Fell SM; Li S; Surova O; Sodersten E; Kogner P; Nyman U; Schlisio S; Holmberg J
Article: GENES & DEVELOPMENT. 2017;31(10):1036-1053
Neuroblast differentiation during development and in neuroblastoma requires KIF1Bβ-mediated transport of TRKA
Fell SM; Li S; Wallis K; Kock A; Surova O; Rraklli V; Hoefig CS; Li W; Mittag J; Henriksson MA; Kenchappa RS; Holmberg J; Kogner P; Schlisio S
Article: ONCOTARGET. 2016;7(23):34229-34239
XAF1 promotes neuroblastoma tumor suppression and is required for KIF1Bβ-mediated apoptosis
Choo Z; Koh RYL; Wallis K; Koh TJW; Kuick CH; Sobrado V; Kenchappa RS; Loh AHP; Soh SY; Schlisio S; Chang KTE; Chen ZX
Article: DEVELOPMENTAL CELL. 2016;36(2):164-178
The 1p36 Tumor Suppressor KIF 1Bβ Is Required for Calcineurin Activation, Controlling Mitochondrial Fission and Apoptosis
Li S; Fell SM; Surova O; Smedler E; Wallis K; Chen ZX; Hellman U; Johnsen JI; Martinsson T; Kenchappa RS; Uhlen P; Kogner P; Schlisio S
Article: HYPOXIA (AUCKL). 2016;4:15-27
The 2-oxoglutarate analog 3-oxoglutarate decreases normoxic hypoxia-inducible factor-1α in cancer cells, induces cell death, and reduces tumor xenograft growth.
Koivunen P; Fell SM; Lu W; Rabinowitz JD; Kung AL; Schlisio S
Article: CANCER DISCOVERY. 2014;4(4):434-451
RNA Helicase A Is a Downstream Mediator of KIF1Bβ Tumor-Suppressor Function in Neuroblastoma
Chen ZX; Wallis K; Fell SM; Sobrado VR; Hemmer MC; Ramskold D; Hellman U; Sandberg R; Kenchappa RS; Martinson T; Johnsen JI; Kogner P; Schlisio S
Article: ENDOCRINE-RELATED CANCER. 2010;18(1):73-83
Mutation analysis of HIF prolyl hydroxylases (PHD/EGLN) in individuals with features of phaeochromocytoma and renal cell carcinoma susceptibility
Astuti D; Ricketts CJ; Chowdhury R; McDonough MA; Gentle D; Kirby G; Schlisio S; Kenchappa RS; Carter BD; Kaelin WGJ; Ratcliffe PJ; Schofield CJ; Latif F; Maher ER
Review: JOURNAL OF CELLULAR AND MOLECULAR MEDICINE. 2009;13(10):4104-4112
Neuronal apoptosis by prolyl hydroxylation: implication in nervous system tumours and the Warburg conundrum
Schlisio S
Article: GENES & DEVELOPMENT. 2008;22(7):884-893
The kinesin KIF1Bβ acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor
Schlisio S; Kenchappa RS; Vredeveld LCW; George RE; Stewart R; Greulich H; Shahriari K; Nguyen NV; Pigny P; Dahia PL; Pomeroy SL; Maris JM; Look AT; Meyerson M; Peeper DS; Carter BD; Kaelin WGJ
Article: NATURE CELL BIOLOGY. 2008;10(3):361-U115
VHL loss actuates a HIF-independent senescence programme mediated by Rb and p400
Young AP; Schlisio S; Minamishima YA; Zhang Q; Li L; Grisanzio C; Signoretti S; Kaelin WGJ
Article: MOLECULAR CELL. 2007;28(1):15-27
pVHL acts as an adaptor to promote the inhibitory phosphorylation of the NF-κB agonist Card9 by CK2
Yang H; Minamishima YA; Yan Q; Schlisio S; Ebert BL; Zhang X; Zhang L; Kim WY; Olumi AF; Kaelin WGJ
Article: CANCER CELL. 2005;8(2):155-167
Neuronal apoptosis linked to EgIN3 prolyl hydroxylase and familial pheochromocytoma genes: Developmental culling and cancer
Lee S; Nakamura E; Yang HF; Wei WY; Linggi MS; Sajan MP; Farese RV; Freeman RS; Carter BD; Kaelin WG; Schlisio S

Susanne Schlisios forskargrupp

Publikationer

Utvalda publikationer

Medarbetare och kontakt

Gruppledare

Alla medarbetare i gruppen